Share on StockTwits

Imprivata Inc (NASDAQ:IMPR) updated its third quarter earnings guidance on Monday. The company provided earnings per share guidance of ($0.17)-(0.14) for the period, compared to the Thomson Reuters consensus earnings per share estimate of ($0.16), American Banking News.com reports. The company issued revenue guidance of $23-24 million, compared to the consensus revenue estimate of $22.74 million.Imprivata also updated its FY14 guidance to ($1.18)-(1.10) EPS.

Several analysts have recently commented on the stock. Analysts at Wells Fargo & Co. initiated coverage on shares of Imprivata in a research note on Monday, July 21st. They set an outperform rating on the stock. On a related note, analysts at William Blair initiated coverage on shares of Imprivata in a research note on Monday, July 21st. They set an outperform rating on the stock. Finally, analysts at JPMorgan Chase & Co. initiated coverage on shares of Imprivata in a research note on Monday, July 21st. They set an overweight rating and a $19.00 price target on the stock.

Imprivata Inc (NASDAQ:IMPR) traded up 0.55% on Monday, hitting $14.55. The stock had a trading volume of 40,152 shares. Imprivata Inc has a 52-week low of $13.30 and a 52-week high of $17.49. The stock’s 50-day moving average is $15.82 and its 200-day moving average is $15.82. The company’s market cap is $332.0 million.

Imprivata (NASDAQ:IMPR) last released its earnings data on Monday, August 4th. The company reported ($0.81) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.39) by $0.42. The company had revenue of $23.20 million for the quarter, compared to the consensus estimate of $22.15 million. The company’s quarterly revenue was up 34.1% on a year-over-year basis. Analysts expect that Imprivata Inc will post $-0.79 EPS for the current fiscal year.

Imprivata Inc is a provider of authentication and access management technology solutions for the healthcare industry.

Receive News & Ratings for Imprivata Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imprivata Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.